AcQblate Force Sensing Ablation System US IDE for Atrial Flutter
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
100 participants needed
1 Location
Brief description of study
The objective of the clinical study is to demonstrate the AcQBlate Force Sensing System is safe and effective when used to ablate the cavotricuspid isthmus (CTI) for the treatment of typical atrial flutter .
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Atrial Flutter
-
Age: 18 years - 99 years
-
Gender: All
Male and Female, Age 18 or older, At least one (1) documented episode of typical atrial flutter within 180 days (6 months)
Updated on
04 Aug 2024.
Study ID: 848386
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
